Discover how in silico tools can be used can be used with organ-on-a-chip for the advancement of ADME studies.

Historically, it was not possible to detect ADME problems until the IND application preparation stage, which often led to “serious disruption of the development process, and often resulted in closure ...

The ARPA-H CATALYST programme aims to transform preclinical drug safety prediction using human-based models.

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 million contract from the Advanced Research Projects Agency for Health (ARPA-H) ...

The ADME/DMPK services at Ace Therapeutics include a comprehensive suite of in vitro and in vivo ADME studies to assess the absorption, distribution, metabolism, and excretion of drug candidates, as ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...